Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Bremell, Daniel ^a   Mattsson, Niklas ^a   Edsbagge, Mikael ^a   Blennow, Kaj ^a   Andreasson, Ulf ^a   Wikkelsö, Carsten ^a   Zetterberg, Henrik ^a,b   Hagberg, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL13 CHEMOKINE; DOXYCYCLINE;

ARTICLE; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FACIAL NERVE PARALYSIS; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONGITUDINAL STUDY; LYME DISEASE; MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RADICULITIS; VIRUS LOAD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHEMOKINE CXCL13; CROSS-SECTIONAL STUDIES; DOXYCYCLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHYLENEDIAMINES; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; MORPHOLINES; RETROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84871906031     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-2     Document Type: Article

References (27)

1. Kaiser R. Neuroborreliosis. J Neurol 1998, 245(5):247-255. 10.1007/s004150050214, 9617704.
2. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010, 17(1):8-16. e11-14, 10.1111/j.1468-1331.2009.02862.x, 19930447.
3. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O'Connell S, Ornstein K, Strle F, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011, 17(1):69-79. 10.1111/j.1469-0691.2010.03175.x, 20132258.
4. Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 1993, 43(1):169-175. 10.1212/WNL.43.1_Part_1.169, 8423881.
5. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol 1991, 30(2):197-205. 10.1002/ana.410300212, 1897911.
6. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005, 65(3):448-450. 10.1212/01.wnl.0000171349.06645.79, 16087912.
7. Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J. The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry 2010, 81(8):929-933. 10.1136/jnnp.2009.195438, 19965843.
8. Ljostad U, Mygland A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 2008, 255(5):732-737. 10.1007/s00415-008-0785-y, 18344056.
9. Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 2010, 37(5):283-287. 2884158, 20393380.
10. van Burgel ND, Bakels F, Kroes AC, van Dam AP. Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid. J Clin Microbiol 2011, 49(5):2027-2030. 10.1128/JCM.00084-11, 3122636, 21367992.
11. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985, 313(24):1493-1497. 10.1056/NEJM198512123132401, 2999591.
12. Chiodi F, Albert J, Olausson E, Norkrans G, Hagberg L, Sonnerborg A, Asjo B, Fenyo EM. Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection. AIDS Res Hum Retroviruses 1988, 4(5):351-358. 10.1089/aid.1988.4.351, 3196491.
13. Widney DP, Breen EC, Boscardin WJ, Kitchen SG, Alcantar JM, Smith JB, Zack JA, Detels R, Martinez-Maza O. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res 2005, 25(11):702-706. 10.1089/jir.2005.25.702, 16318584.
14. Läkemedelsbehandling av borreliainfektion - ny rekommendation. vol. 4: Läkemedelsverket 2009, The Swedish Medical Products Agency.
15. Edsbagge M, Starck G, Zetterberg H, Ziegelitz D, Wikkelso C. Spinal cerebrospinal fluid volume in healthy elderly individuals. Clin Anat 2011, 24(6):733-740. 10.1002/ca.21153, 21412855.
16. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991, 37(7):1153-1160.
17. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992, 115(Pt 2):399-423.
18. Strle F, Ruzic-Sabljic E, Cimperman J, Lotric-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 2006, 43(6):704-710. 10.1086/506936, 16912943.
19. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988, 45(9):954-958. 10.1001/archneur.1988.00520330032007, 2970837.
20. Courtioux B, Pervieux L, Vatunga G, Marin B, Josenando T, Jauberteau-Marchan MO, Bouteille B, Bisser S. Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis. Trop Med Int Health 2009, 14(5):529-534. 10.1111/j.1365-3156.2009.02263.x, 19298637.
21. Serrano P, Hernandez N, Arroyo JA, de Llobet JM, Domingo P. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis 2007, 44(6):e57-61. 10.1086/511876, 17304442.
22. Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, Grutzmeier S, Racz P, Chiodi F, Nilsson A. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood 2008, 112(12):4401-4410. 10.1182/blood-2008-02-140426, 18780835.
23. Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011, 76(12):1051-1058. 10.1212/WNL.0b013e318211c39a, 21422457.
24. Wutte N, Berghold A, Loffler S, Zenz W, Daghofer E, Krainberger I, Kleinert G, Aberer E. CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand 2011, 124(5):321-328. 10.1111/j.1600-0404.2010.01477.x, 21320077.
25. Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect 2011, 62(2):149-158. 10.1016/j.jinf.2010.11.005, 21087629.
26. Mattsson N, Blennow K, Zetterberg H. Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall. Clin Chem Lab Med 2010, 48(5):603-607.
27. Bjerke M, Portelius E, Minthon L, Wallin A, Anckarsater H, Anckarsater R, Andreasen N, Zetterberg H, Andreasson U, Blennow K. Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimers Dis 2010, 2010. Article ID 986310.